Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Consulting agrmnt
Aditxt, Inc. (ADTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
10/05/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/21/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT TO SEPARATION AGREEMENT AND GENERAL RELEASE DATED AUGUST 15, 2023"
08/18/2023 8-K Quarterly results
08/17/2023 8-K Quarterly results
08/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
07/28/2023 8-K Quarterly results
07/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation Agreement and General Release by and between Matthew Shatzkes and Aditxt, Inc"
07/14/2023 8-K Quarterly results
07/07/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "FORM OF SECURITIES PURCHASE AGREEMENT",
"FORM OF NOTE",
"FORM OF SECURITY AGREEMENT",
"FORM OF REGISTRATION RIGHTS AGREEMENT",
"FORM OF BUSINESS LOAN AND SECURITY AGREEMENT DATED JULY 3, 2023"
06/30/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
06/16/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Even...
Docs: "FORM OF UNSECURED PROMISSORY NOTE"
05/31/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "FORM OF AGREEMENT FOR THE PURCHASE AND SALE OF FUTURE RECEIPTS",
"UNSECURED PROMISSORY NOTE DATED MAY 25, 2023"
05/26/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
04/28/2023 8-K Quarterly results
04/25/2023 8-K Quarterly results
04/24/2023 8-K Quarterly results
04/17/2023 8-K Quarterly results
03/21/2023 8-K Entered into consulting agreement
Docs: "FORM OF CONSULTING AGREEMENT"
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
02/24/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
01/20/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
01/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
12/23/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "AMENDMENT NO. 2 TO SERIES C WARRANT AGENT AGREEMENT",
"FORM OF AMENDED AND RESTATED UNIT PURCHASE OPTION"
12/20/2022 8-K Quarterly results
12/02/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
10/03/2022 8-K Quarterly results
09/20/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "RICHMOND, Va., - September 16, 2022 - Aditxt, Inc., , a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the pricing of a public offering of 3,333,333 shares of its common stock , together with warrants to purchase up to 3,333,333 shares of its common stock at a combined offering price to the public of $6.00 per share and associated warrants. The warrants will have an exercise price of $6.00 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance. The closing of the offering is expected to occur on or about September 20, 2022, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placeme...",
"RICHMOND, Va., - September 20, 2022 - Aditxt, Inc., , a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the closing of its previously announced public offering of 3,333,333 shares of its common stock , together with warrants to purchase up to 3,333,333 shares of its common stock at a combined offering price to the public of $6.00 per share and associated warrant. The warrants have an exercise price of $6.00 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The gross proceeds to the Company from the offering were approximately $20.0 million, before deducting..."
09/14/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF ADITXT, INC",
"FORM OF AUGUST 2022 NOTE",
"FORM OF AUGUST 2022 WARRANT",
"Aditxt, Inc. Announces 1-for-50 Reverse Stock Split Effective Pre-Market Opening on September 14, 2022"
09/07/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Submission of Matters to a Vote of Secur...
Docs: "FORM OF FIRST AMENDMENT AND WAIVER EFFECTIVE AS OF AUGUST 31, 2022",
"FORM OF WARRANT"
08/26/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/17/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy